Partex.AI Therapeutics
AI-enabled drug development
- B2B
- AI-native
About Partex.AI Therapeutics
An asset management and biotechnology company utilizing AI to in-license drug candidates, optimize clinical development, and secure agile drug development through specialized subsidiaries
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- zug, Switzerland
- Founded
- 2021
- Revenue
- $3.5M – $27.6MTamtam estimate
- Website
- cureteq.com
- linkedin.com/company/cureteq
Partex.AI Therapeutics at a glance
Partex.AI Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in zug, Switzerland.
Partex.AI Therapeutics was founded in 2021.
Partex.AI Therapeutics has 1–10 employees.
Partex.AI Therapeutics's revenue is $3.5M – $27.6M (Tamtam estimate).
Frequently asked questions about Partex.AI Therapeutics
What is Partex.AI Therapeutics's revenue?
Tamtam estimates Partex.AI Therapeutics's annual revenue at $3.5M – $27.6M.
How many employees does Partex.AI Therapeutics have?
Partex.AI Therapeutics has 1–10 employees.
Where is Partex.AI Therapeutics headquartered?
Partex.AI Therapeutics is headquartered in zug, Switzerland.
Selling to companies like Partex.AI Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies